Skip to content
1st Counsel – Lifestyle
Author:
NEKTAR THERAPEUTICS
Nektar to Hold Conference Call to Discuss 52-Week Topline Results from the 16-Week Extension Treatment Period for its REZOLVE-AA Phase 2b Study of Rezpegaldesleukin in Alopecia Areata on April 20, 2026
April 19, 2026
←
Previous Page
1
2
3